Free Submission Public Relations &
Deutsch English

Joint reconstruction market led by Zimmer Holdings with a 22.9% share

Joint reconstruction market led by Zimmer Holdings with a 22.9% share

Print article Print article
2012-12-04 16:58:58 - Joint reconstruction market led by Zimmer Holdings with a 22.9% share

The joint reconstruction market has been forecast to increase at a compound annual growth rate (CAGR) of 3.7% over the next six years, increasing from a valuation of $13.5 billion in 2011, to hit a market value of $17.5 billion by 2018.Osteoarthritis or injury can cause severe pain in the hips and knees, therefore reconstruction of those joints can be the best way to regain function and restore quality of life. The hip enables us to bend and straighten our body and move our lower limbs, while the knee, the largest hinge-type joint in the body, is prone to injury. When either joint is severely damaged, activities such as walking or participating in sports can become impossible.The market will witness



strong growth through to 2018, primarily driven by a growing aging population and the increasing incidence of obesity. Osteoarthritis is the most common musculoskeletal disease affecting people aged above 60 years, causing a surge in hip and knee replacement surgeries. Moreover, increased direct-to-consumer marketing has raised awareness of available treatments, fuelling joint reconstruction market growth.The knee reconstruction category is the largest in terms of revenue and is forecast to reach $9 billion in 2018, while the hip reconstruction category is expected to grow at a CAGR of 4.2% to $8.5 billion.Five leading companies - Zimmer, DePuy, Stryker, Smith & Nephew and Biomet control 90% of the large joint reconstruction market. Each of these companies has an extensive portfolio of time tested hip and knee implants.In 2011, Zimmer Holdings, Inc. accounted for 22.9% of the global joint reconstruction market. Its knee reconstruction product line has driven its overall growth. In second and third place, DePuy and Stryker accounted for 21.8% and 18.3% of the total joint reconstruction market respectively. Both companies´ products witnessed strong growth in 2011.For more information on the joint reconstruction market, see the latest research: Joint Reconstruction MarketFollow us on Twitter @CandMResearch

Click for news details: ..

Browse all Healthcare and Medical C&M News ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact